Lipoprotein abnormalities in diabetic nephropathy

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Implementing KDOQI CKD Definition and Staging Guidelines in Southern California Kaiser Permanente Mark Rutkowski, MD, Wendy Mann, PharmD, Stephen Derose,

Ischemic heart disease after renal transplantation

Volume 56, Pages S238-S241 (July 1999)

Steven Fishbane, Jeffrey S. Berns, M.D. Kidney International

Anemia management in chronic kidney disease

End-stage renal disease in developing countries

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

Volume 83, Issue 3, Pages (March 2013)

Lipopheresis in the nephrotic syndrome

Epidemiology of diabetic nephropathy in Spain

From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria Paul E. De Jong, Barry M. Brenner Kidney International

Naïve and central memory T-cell lymphopenia in end-stage renal disease

II. assessment of dyslipidemias

Progression of renal failure and hypertensive nephrosclerosis

Peter Rossing, Philip Hougaard, Hans-Henrik Parving

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Francesco Paolo Schena Kidney International

Volume 70, Pages S21-S25 (December 2006)

Volume 57, Pages S32-S37 (April 2000)

George A. Kaysen, Burl R. Don

Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease Johannes F.E. Mann, Qi-Long.

C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go

Abnormalities in lipoprotein metabolism in hemodialysis patients

Comorbidity and confounding in end-stage renal disease

Volume 60, Issue 6, Pages (December 2001)

Per-Ola Attman, M.D, Petar Alaupovic, Ola Samuelsson

N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment Martina Franz, Wolfgang Woloszczuk, Walter.

Volume 70, Issue 11, Pages (December 2006)

The epidemiology of chronic kidney disease

Study of Heart and Renal Protection (SHARP)

Volume 73, Pages S5-S17 (April 2008)

Acute myocardial infarction in patients with end-stage renal disease

Volume 70, Issue 12, Pages (December 2006)

Volume 62, Issue 4, Pages (October 2002)

Volume 67, Pages S48-S51 (January 2005)

Blood pressure targets in hemodialysis patients

Volume 73, Issue 9, Pages (May 2008)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 87, Issue 1, Pages (January 2015)

Volume 67, Issue 4, Pages (April 2005)

Simvastatin in nephrotic syndrome

Counteracting progression of renal disease: A look into the future

Volume 63, Issue 6, Pages (June 2003)

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Lynda Anne Szczech, Ira L. Lazar Kidney International

Volume 56, Pages S235-S237 (July 1999)

Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients Florian Kronenberg, Arno Lingenhel, Ulrich Neyer, Karl Lhotta, Paul König, Martin.

Volume 56, Pages S213-S215 (July 1999)

Volume 64, Issue 2, Pages (August 2003)

Atherosclerotic nephropathy

Volume 66, Issue 1, Pages (July 2004)

Volume 55, Pages S3-S16 (June 1999)

Early detection and prevention of diabetic nephropathy: A challenge calling for mandatory action for Mexico and the developing world Ricardo Correa-Rotter,

Volume 56, Pages S238-S241 (July 1999)

Volume 80, Issue 10, Pages (November 2011)

Volume 56, Pages S28-S30 (July 1999)

Sandra Blanco, Rosa Penin, Irma Casas, Dolores López, Ramón Romero

Charles A. Herzog Kidney International

Volume 56, Pages S254-S255 (July 1999)

Renal replacement therapy in Latin America

Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa

Volume 70, Issue 5, Pages (September 2006)

Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton

Membranous nephropathy: recent travels and new roads ahead

Ischemic heart disease after renal transplantation

Volume 55, Issue 3, Pages (March 1999)

Evaluation of the Losartan in Hemodialysis (ELHE) Study

Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies Lei-Shi Li, Zhi-Hong Liu Kidney International

Presentation transcript:

Lipoprotein abnormalities in diabetic nephropathy Tsutomu Hirano, M.D Kidney International Volume 56, Pages S22-S24 (July 1999) DOI: 10.1046/j.1523-1755.1999.07106.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Plasma triglyceride concentrations in type 2 diabetic patients without and with nephropathy. Data represent mean ± SEM.aP < 0.05 vs. controls by analysis of variance. Abbreviations are: DM, diabetes mellitus; micro, microalbuminuria; overt, overt proteinuria. Kidney International 1999 56, S22-S24DOI: (10.1046/j.1523-1755.1999.07106.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 Comparison of low-density lipoprotein (LDL) particle diameter between controls (Cont), type 2 diabetic patients (DM) with various degrees of albuminuria, and primary renal disease patients (PRD). Data represent mean ± SEM. Hemodialysis (HD) and PRD patients received hemodialysis. aP < 0.05 vs. controls; bP < 0.05 vs. normoalbuminuric DM; cP < 0.05 vs. PRD without HD; dP < 0.05 vs. PRD with HD, by analysis of variance. Kidney International 1999 56, S22-S24DOI: (10.1046/j.1523-1755.1999.07106.x) Copyright © 1999 International Society of Nephrology Terms and Conditions